Back to Teaser

UK regulators to take a lighter touch on mergers?

UK 7 min read
Author
Daniel Black

Hello, 

Uncertainty seems to be the key theme of recent weeks. In response, UK interest rates were held at 4.5% on Thursday, with the Bank of England saying it was waiting to see the impact of US tariffs.

It’s making life difficult for dealmakers, with both M&A and IPOs on hold while people wait for something nearing clarity on economic policy and tariffs. One piece of good news though – Chancellor Rachel Reeves plans to restrict the CMA’s merger investigations as part of a bid to boost UK corporate confidence and ease regulations. 

Also making the headlines this week:

  • Apollo is to buy energy group OEG for $1bn
  • Carlyle’s $945m Energean deal is facing collapse
  • AstraZeneca will pay up to $1bn for cell therapy firm EsoBiotec

Thanks for reading, and do connect with me on LinkedIn.

Deal Tracker

Our weekly roundup of all the confirmed M&A deals in the UK.

TransactionSectorsBuyer
01

Celnor Group expands into US with acquisition of John Turner Consulting

Business Services

Celnor Group

02

Shell sold Shell Petroleum Development Co to Renaissance

Energy

Renaissance

03

Diversified Energy acquired Maverick Natural Resources

Energy

Diversified Co PLC

04

Harmony Energy sold a 200-MW battery storage in Poland to a local EDF unit

Energy

05

NextPower UK ESG acquired a 56-MW ready-to-build PV, 16-MW battery storage in S.Yorkshire

Energy

NextPower UK ESG (NPUK)

06

Equitix acquired 122.5-MWp onshore wind bundle in UK

Energy

Equitix

07

Iberdrola acquired 88% stake in North West Electricity Networks (Jersey) Limited

Energy

Iberdola

08

Pfizer sold entire stake in Haleon, offloading approx.662m shares

Healthcare/pharma

09

Bspoke acquired Arma Karma

Insurance

Bspoke Group

10

Howden Scotland acquired the book of business from SKB Independent Insurance Brokers

Insurance

Howden Scotland

11

Shaftesbury sold 25% stake in Covent Garden estate to Norwegians for £570m

Real estate

Norwegian sovereign wealth fund

The rumour mill

Salaries and bonuses

Job moves

Market trends

A gloomy economic outlook?

It’s not been the rebound many had hoped for. Analysis published this week by RSM UK shows UK economic growth is set to remain sluggish going further into mid 2025, with GDP expected to rise by a modest 1%, dampened by global trade uncertainty and weak external demand. Inflation is forecast to tick back up to nearly 4%, consequently raising concerns about a return to stagnation. While real household disposable incomes grew by 4% last year, consumer spending has barely moved. 

Further adding to the concerns, UK production output took a hit in early 2025, with January’s figures showing 0.9% month-on-month decline to its lowest since May 2020. Manufacturing, which was down 1.1%, was one of the key contributors to the decline, alongside notable drops in basic metals and pharmaceuticals. Mining and quarrying saw an even larger drop of 3.3%. 

The ONS data shows that production output for the three months to January 2025 was estimated to have decreased by 0.9% compared with the three months to October 2024; this is the ninth consecutive three-monthly decline in production output.

from GDP monthly estimate, UK: January 2025 

All in all, not the best outlook for the UK. However, RSM’s analysts do conclude that “things aren’t as bad as they seem at first glance.” 

“Growth should still improve throughout the year and the surge in inflation is likely to be temporary. But it now seems like we’ll have to wait until 2026 before a return to ‘normal’.”

M&A goes nuclear

A nuclear renaissance is underway in Europe, which could be good news for dealmakers. With data centres consuming massive amounts of energy, the need for reliable, low-carbon energy solutions is pushing industries to look toward atomic energy. 

France is leading the charge, with the overall momentum also extending to the UK where the Hinkley Point C project, one of Europe’s largest nuclear initiatives, is a major focus for investment. 

According to MergerMarket, nuclear dealmaking is beginning to boom as a result. In 2024, deal value in Europe grew to EUR 886m across 15 deals, compared to EUR 160m over 20 transactions in 2023.

Cautious approach: IPOs hit pause

New data suggests that European IPO issuers are pausing as US market volatility and trade tensions create uncertainty. Expected deals, like Blackstone-backed Cirsa, are being delayed, with market conditions making it risky to launch new listings.  

This comes off the back of last week’s update on Bain’s decision to shelve its IPO plans in favour of a £5bn sale of its Kantar assets.

Fundraising